Role of Pharmacogenomics in drug developmentHAKONARSSON, Hakon; STEFANSSON, Kari.Drug development research. 2004, Vol 62, Num 2, pp 86-96, issn 0272-4391, 11 p.Article

Recent developments in tuberculosis vaccinesMARINOVA, Dessislava; GONZALO-ASENSIO, Jesus; AGUILO, Nacho et al.Expert review of vaccines. 2013, Vol 12, Num 12, pp 1431-1448, issn 1476-0584, 18 p.Article

Fabrication of Paclitaxel Nanocrystals by Femtosecond Laser Ablation and FragmentationKENTH, Sukhdeep; SYLVESTRE, Jean-Philippe; FUHRMANN, Kathrin et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 3, pp 1022-1030, issn 0022-3549, 9 p.Article

Therapies for Inborn Errors of Metabolism: What Has the Orphan Drug Act Delivered?TALELE, Sonali S; KUI XU; PARISER, Anne R et al.Pediatrics (Evanston). 2010, Vol 126, Num 1, pp 101-106, issn 0031-4005, 6 p.Article

Late-stage clinical development in lower urogenital targets : sexual dysfunctionAZAM, Usman.British journal of pharmacology. 2006, Vol 147, issn 0007-1188, S153-S159, SUP2Conference Paper

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical developmentKUSHNIR, Natasha; STREATFIELD, Stephen J; YUSIBOV, Vidadi et al.Vaccine. 2012, Vol 31, Num 1, pp 58-83, issn 0264-410X, 26 p.Article

Treatment of Na_v1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blockerGOLDBERG, Yigal Paul; PRICE, Nicola; NEIL PIMSTONE, Simon et al.Pain (Amsterdam). 2012, Vol 153, Num 1, pp 80-85, issn 0304-3959, 6 p.Article

Prevention of tick-borne encephalitis by FSME-IMMUN^® vaccines: Review of a clinical development programmeLOEW-BASELLI, Alexandra; POELLABAUER, Eva Maria; PAVLOVA, Borislava G et al.Vaccine. 2011, Vol 29, Num 43, pp 7307-7319, issn 0264-410X, 13 p.Article